Molecular docking and QSAR of aplyronine A and analogues: potent inhibitors of actin Abrar HussainJames L. MelvilleJonathan D. Hirst OriginalPaper 05 November 2009 Pages: 1 - 15
How the energy evaluation method used in the geometry optimization step affect the quality of the subsequent QSAR/QSPR models Åsmund RinnanNiels Johan ChristensenSøren Balling Engelsen OriginalPaper 27 November 2009 Pages: 17 - 22
Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability Yongbo HuRay UnwallaChristine Humblet OriginalPaper 24 November 2009 Pages: 23 - 35
Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity Liang ChangChanghai ZhouJing Liu OriginalPaper 12 December 2009 Pages: 37 - 47
Artificial neural network study on organ-targeting peptides Eunkyoung JungJunhyoung KimDong Hyun Jung OriginalPaper 18 December 2009 Pages: 49 - 56
A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors Hamed I. AliTakayuki FujitaTomohisa Nagamatsu OriginalPaper 29 December 2009 Pages: 57 - 75
Characterization of dipeptidylcarboxypeptidase of Leishmania donovani: a molecular model for structure based design of antileishmanials Mirza Saqib BaigAshutosh KumarNeena Goyal OriginalPaper 29 December 2009 Pages: 77 - 87